Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jpeds.2016.08.078 | DOI Listing |
J Dermatol
December 2024
Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
Bullous pemphigoid (BP) is the most prevalent autoimmune blistering disorder, triggered by autoantibodies targeting hemidesmosome components. It is associated with substantial morbidity and increased mortality. No studies comprehensively evaluate all comorbidities before and after diagnosing patients with BP.
View Article and Find Full Text PDFActa Derm Venereol
December 2024
Université Paris Cité, Inserm, UMR 1163, Institut Imagine, Laboratory of genetic skin diseases, Paris, France; Department of Genomic Medicine of Rare Diseases, AP-HP, Hôpital Necker-Enfants Malades, Paris, France.
Am J Trop Med Hyg
September 2024
Hospital for Skin Diseases, Shandong First Medical University; Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Dermatol Reports
June 2024
Department of Dermatology, Ruhr-University of Bochum.
Aust J Gen Pract
December 2023
MBBS (Hons), MPhil, FACD, Consultant Dermatologist, Dermatology Department, Northern Hospital, Melbourne, Vic; Consultant Dermatologist, Preston Dermatology and Specialist Centre, Melbourne, Vic.
Background: Older patients with a red scaly eruption often present first to a primary care practitioner. A thorough clinical assessment can help delineate between common causes and assist the clinician with the next steps in management.
Objective: This article discusses the assessment of acute- to subacute-onset erythematous and scaly plaques that are present on multiple body sites in a patient aged >65 years.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!